Multiple Sclerosis: The Role of Primary Care in Early Diagnosis and Patient-centered Management

Multiple sclerosis (MS) is a progressive disease of the central nervous system. It affects approximately 1 million people in the US and is most commonly diagnosed between the ages of 20 and 50 years, largely in women. MS causes a variety of motor and nonmotor symptoms and can have devastating effects on productivity and quality of life. This program will review the signs and symptoms of MS to best facilitate early referral for comprehensive neurologic work-up and initiation of disease-modifying therapy (DMT). It will also discuss the primary care clinician’s role in coordinating care, counseling on DMT adherence, and managing the comorbidities of MS.
Mary Knudtson, DNSc, NP, FAAN
Claire Riley, MD
Released: January 24, 2020

Information on this Educational Activity

Faculty

Claire Riley, MD

Assistant Professor of Neurology
Columbia Irving Medical Center
Medical Director
Columbia University Multiple Sclerosis Center
New York, New York

Dr Riley: advisory board: EMD Serono, Genentech, Genzyme; speaker: Biogen.
Mary Knudtson, DNSc, NP, FAAN
Associate Vice Chancellor
Student Health and Wellness
Executive Director
Student Health Services
University of California, Santa Cruz
Santa Cruz, California
Professor of Clinical Nursing
University of California, Irvine
Irvine Irvine, California

 

Dr Knudtson has no relevant financial relationships to disclose.

Target Audience

NPs and PAs

Program Medium

This program has been made available online.

Related Content

Clinical Care Options (CCO) interactive Medical Minute activity of faculty expert and a patient with MS discussing therapies for progressive MS and management of MS symptoms

Daniel Kantor, MD, FAAN
Program Director
person default Shirley Nedzesky
Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.5 Nursing contact hours Released: November 15, 2021 Expired: November 14, 2022

Clinical Care Options (CCO) downloadable slideset of faculty expert and a patient with MS discussing therapies for progressive MS and management of MS symptoms

Daniel Kantor, MD, FAAN
Program Director
person default Shirley Nedzesky
Released: November 15, 2021

Listen to one of the world’s leading experts discuss the future of pharmacotherapies for psychiatric disorders. Earn 1 hour of CME/CE credit for free in this online webcast.

Greg W. Mattingly, MD Physicians: maximum of 1.25 AMA PRA Category 1 Credits Registered Nurses: 1.2 Nursing contact hours Pharmacists: 1.25 contact hours (0.125 CEUs) Physician Assistants: maximum of 1.25 hours of AAPA Category I (Preapproved) credits Released: March 15, 2020 Expired: No longer available for credit

Jiwon Oh, MD, PhD, FRCPC James M. Stankiewicz, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits Released: August 30, 2019 Expired: No longer available for credit
Provided by Continuing Nursing Education Provider Unit, Boston University School of Medicine

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

This activity is supported by an educational grant from
Novartis Pharmaceuticals Corporation

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings